Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
In this week’s Pathways Picks: FDA finalizes plan to downclassify AI-based skin cancer detections despite cautions from its advisory panel; the EU expands “well-established technologies” list subject to simplified rules; Chile builds out its regulatory framework; AI and digital health news; and more to watch from China, Canada, and Europe.
An update on a company bringing localized, immediate, and beam-free radiotherapy to brain cancer patients.
FDA finalizes weight-loss tech guide and plans new adverse event database. Excerpted from Pathways’ Picks March 18: MDR Discussions, EtO Revisions, and More Medtech Policy Updates.